1,000
Participants
Start Date
September 1, 2024
Primary Completion Date
October 13, 2024
Study Completion Date
October 17, 2024
Tumor Necrosis Factor
This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
Interleukin-1β
This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
Interleukin-12
This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
Interleukin-18
This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
Complement C3
This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
Complement C5
This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.
Xiue Ye, Wenzhou
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,, Wenzhou
Second Affiliated Hospital of Wenzhou Medical University
OTHER